• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of pembrolizumab-induced toxic epidermal necrolysis with a delayed developmental timeline.

作者信息

Driscoll William, Yale Katerina, Smith Janellen

机构信息

Department of Dermatology, University of California, Irvine, Irvine, California.

出版信息

JAAD Case Rep. 2024 Aug 30;53:27-29. doi: 10.1016/j.jdcr.2024.08.011. eCollection 2024 Nov.

DOI:10.1016/j.jdcr.2024.08.011
PMID:39435162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11491971/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/11491971/613b8127f2ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/11491971/613b8127f2ba/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b40e/11491971/613b8127f2ba/gr1.jpg

相似文献

1
A case of pembrolizumab-induced toxic epidermal necrolysis with a delayed developmental timeline.一例帕博利珠单抗诱导的中毒性表皮坏死松解症，其病程发展延迟。
JAAD Case Rep. 2024 Aug 30;53:27-29. doi: 10.1016/j.jdcr.2024.08.011. eCollection 2024 Nov.
2
Toxic epidermal necrolysis associated with pembrolizumab.与帕博利珠单抗相关的中毒性表皮坏死松解症。
J Oncol Pharm Pract. 2020 Jul;26(5):1259-1265. doi: 10.1177/1078155219890659. Epub 2019 Dec 6.
3
Cutaneous Stevens Johnson - Toxic Epidermal Necrolysis Immunotherapy related Toxicities in Lung Cancer Patients.皮肤性史蒂文斯-约翰逊综合征 - 中毒性表皮坏死松解症与肺癌患者免疫治疗相关的毒性。
J Oncol Pharm Pract. 2022 Jul;28(5):1276-1282. doi: 10.1177/10781552221074623. Epub 2022 Jan 18.
4
Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症：触发因素分析及对改进预防措施的启示
Am J Med. 2016 Nov;129(11):1221-1225. doi: 10.1016/j.amjmed.2016.03.022. Epub 2016 Apr 15.
5
Pembrolizumab-induced Stevens-Johnson syndrome/Toxic Epidermal Necrolysis in a Vietnamese patient with nonsmall-cell lung cancer.一名越南非小细胞肺癌患者发生帕博利珠单抗诱导的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症。
Asia Pac Allergy. 2024 Jun;14(2):84-89. doi: 10.5415/apallergy.0000000000000131. Epub 2023 Dec 18.
6
Pembrolizumab-induced Toxic Epidermal Necrolysis in a Patient with Metastatic Esophageal Adenocarcinoma.帕博利珠单抗诱发的转移性食管腺癌患者中毒性表皮坏死松解症
R I Med J (2013). 2022 Apr 1;105(3):34-36.
7
Assessing carbamazepine and oxcarbazepine-associated Stevens-Johnson syndrome/toxic epidermal necrolysis: Data mining the public version of the FDA adverse event reporting system.评估卡马西平和奥卡西平相关的史蒂文斯-约翰逊综合征/中毒性表皮坏死松解症：从 FDA 不良事件报告系统公开版本中挖掘数据。
Int J Clin Pract. 2021 Aug;75(8):e14273. doi: 10.1111/ijcp.14273. Epub 2021 May 17.
8
Cutaneous Immune-Related Adverse Events (irAEs) to Immune Checkpoint Inhibitors: A Dermatology Perspective on Management.免疫检查点抑制剂相关的皮肤免疫不良反应（irAEs）：皮肤科管理视角
J Cutan Med Surg. 2021 Jan-Feb;25(1):59-76. doi: 10.1177/1203475420943260. Epub 2020 Aug 3.
9
Stevens-Johnson syndrome and toxic epidermal necrolysis-like eruptions in patients treated with immune checkpoint inhibitors: a systematic review.免疫检查点抑制剂治疗患者的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症样皮疹：系统评价。
Int J Dermatol. 2024 Dec;63(12):e397-e404. doi: 10.1111/ijd.17479. Epub 2024 Sep 16.
10
Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.与选择性环氧化酶-2抑制剂相关的史蒂文斯-约翰逊综合征和中毒性表皮坏死松解症报告情况的比较。
Drug Saf. 2005;28(10):917-24. doi: 10.2165/00002018-200528100-00008.

本文引用的文献

1
Immune checkpoint inhibitor-induced epidermal necrolysis: A narrative review evaluating demographics, clinical features, and culprit medications.免疫检查点抑制剂诱导的表皮坏死松解症：评估人口统计学、临床特征和罪魁祸首药物的叙述性综述。
J Dermatol. 2024 Jan;51(1):3-11. doi: 10.1111/1346-8138.17039. Epub 2023 Nov 30.
2
Pembrolizumab-induced toxic epidermal necrolysis: case report.帕博利珠单抗诱发中毒性表皮坏死松解症：病例报告。
Oxf Med Case Reports. 2022 Mar 16;2022(3):omac025. doi: 10.1093/omcr/omac025. eCollection 2022 Mar.
3
Generalized bullous mucocutaneous eruption mimicking Stevens-Johnson syndrome in the setting of immune checkpoint inhibition: A multicenter case series.
免疫检查点抑制背景下酷似史蒂文斯-约翰逊综合征的泛发性大疱性黏膜皮肤疹：一项多中心病例系列研究
J Am Acad Dermatol. 2020 Nov;83(5):1475-1477. doi: 10.1016/j.jaad.2020.03.029. Epub 2020 Mar 19.
4
Dermatologic Reactions to Immune Checkpoint Inhibitors : Skin Toxicities and Immunotherapy.免疫检查点抑制剂的皮肤不良反应：皮肤毒性与免疫治疗
Am J Clin Dermatol. 2018 Jun;19(3):345-361. doi: 10.1007/s40257-017-0336-3.
5
Recent development in clinical applications of PD-1 and PD-L1 antibodies for cancer immunotherapy.癌症免疫治疗中 PD-1 和 PD-L1 抗体的临床应用最新进展。
J Hematol Oncol. 2017 Dec 1;10(1):174. doi: 10.1186/s13045-017-0541-9.
6
Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis.中毒性表皮坏死松解症：第一部分。引言、历史、分类、临床特征、全身表现、病因和免疫发病机制。
J Am Acad Dermatol. 2013 Aug;69(2):173.e1-13; quiz 185-6. doi: 10.1016/j.jaad.2013.05.003.
7
Toxic epidermal necrolysis clinical guidelines.中毒性表皮坏死松解症临床指南。
J Burn Care Res. 2008 Sep-Oct;29(5):706-12. doi: 10.1097/BCR.0b013e3181848bb1.